Bavituximab decreases immunosuppressive myeloid-derived suppressor cells in newly diagnosed glioblastoma patients. Ly KI, Richardson LG, Liu M, Muzikansky A, et al. Clin Cancer Res 2023 Jun 16:CCR-23-0203. doi: 10.1158/1078-0432.CCR-23-0203.

Read + Share

Amedeo Smart

Independent Medical Education

Ly KI, Richardson LG, Liu M, Muzikansky A, et al. Bavituximab decreases immunosuppressive myeloid-derived suppressor cells in newly diagnosed glioblastoma patients. Clin Cancer Res 2023 Jun 16:CCR-23-0203. doi: 10.1158/1078-0432.CCR-23-0203.
PMID: 37327319